0001209191-15-003151.txt : 20150108 0001209191-15-003151.hdr.sgml : 20150108 20150108162907 ACCESSION NUMBER: 0001209191-15-003151 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150106 FILED AS OF DATE: 20150108 DATE AS OF CHANGE: 20150108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001325879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 650 E. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6172995000 MAIL ADDRESS: STREET 1: 650 E. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAILEY MICHAEL P CENTRAL INDEX KEY: 0001255856 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34655 FILM NUMBER: 15516730 BUSINESS ADDRESS: STREET 1: IMCLONE SYSTEMS INCORPORATED STREET 2: 180 VARICK STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 6466385078 MAIL ADDRESS: STREET 1: IMCLONE SYSTEMS INCORPORATED STREET 2: 180 VARICK STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-01-06 0 0001325879 AVEO PHARMACEUTICALS INC AVEO 0001255856 BAILEY MICHAEL P C/O AVEO PHARMACEUTICALS, INC. 650 E. KENDALL STREET CAMBRIDGE MA 02142 1 1 0 0 President & CEO Common Stock 2015-01-06 4 D 0 13200 0.00 D 21519 D Common Stock 2015-01-07 4 S 0 4484 0.8003 D 17035 D Stock Option (right to buy) 0.84 2015-01-06 4 A 0 900000 0.00 A 2025-01-06 Common Stock 900000 900000 D Shares underlying such disposition to the issuer were forfeited by the reporting person pursuant to the terms of an award of restricted stock granted to the reporting person on June 26, 2013 in connection with the determination of the issuer's Compensation Committee that certain specified strategic performance objectives were not met. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2013, which was implemented to cover taxable events related to the partial vesting of certain restricted stock. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.78 to $0.82, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. This option vests in equal monthly installments from January 6, 2015 through January 6, 2019. /s/Joseph D. Vittiglio, Esq., attorney-in-fact 2015-01-08